Abstract 5432: Targeted alpha therapy with 212Pb-NNV003 in treatment of NHL
Jostein Dahle(Oslo University Hospital), Julien Torgue(Orano (France)), Tania A. Rozgaja Stallons(Orano (United States)), Amal Saidi(Orano (France)), Helèn Heyerdahl(Nordic Nanovector (Norway)), Ada H. V. Repetto‐Llamazares(Nordic Nanovector (Norway))
Cited by 1
Related Papers
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
|Photochemistry and Photobiology|1995|181
Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues
|Cancer Letters|1997|68
Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumab
|PLoS ONE|2012|63
<title>Photodynamic therapy with 5-aminoolevulinic acid-induced porphyrins and DMSO/EDTA for basal cell carcinoma</title>
|Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE|1994|60